18th Anglonordic Life Science Conference
Thanks to everyone who came to London to make such a success of Anglonordic's return as an in-person event.
286 Partnering Meetings
26 Startup Pitches
Anglonordic is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other. With an established format of panel discussions, parallel technology and biotech investment rooms, plus 1:1 meetings, this conference provides exceptional value.
Special thanks to H.E. the Ambassador of Denmark to the UK for hosting the exclusive Anglonordic Drinks Reception at his Central London Residence.
2022 Investors attending included:
3B Future Health Ventures, 4BIO Capital, ABG Sundal Collier, Advent Life Sciences, Albion Technology & General VCT, Alpha Blue Ocean, Apple Tree Partners, Apposite Capital, Arix Bioscience, Atlas Capital Markets, Axilium Holding AB, Biotechnology Business Institute, Bioqube Ventures, Bootstrap Europe, Cascara Ventures, Cathay Capital, Convergence Partners, CS Life Science Invest, Curam Capital Management, DeBere Capital Partners, Deep Science Ventures, Eli Lilly, Epidarex Capital, Esperante, European Investment Fund, Forbion, Gebro Pharma, GIMV, GL Capital, Global Health Investment Corporation, HealthCap, i2020 Accelerator, Ignite Capital Partners, Industrifonden, Intermediate Capital Group, IP Group, IPF Partners, INKEF Capital, JJDC, Kreos Capital, Kurma Partners, LifeArc Ventures, Limerston Capital Partners, Livzon, MP Healthcare Venture Management, M Ventures, Medicxi, Monograph, MVM, +ND Capital, New Science Global Healthcare Fund, NG Bio, Norgine Ventures, Novo Holdings, o2h Ventures, Optum Ventures, Ovata Capital, Panakes Partners, Parkwalk, Rosetta Capital, Ruffena Capital, RYSE Asset Management, Seventure, Silicon Valley Bank (SVB), Sofinnova Partners, Softbank, Sound Bioventures, Sunstone Life Science Ventures, Syncona, Ventac Partners, Ysios Capital Partners.